Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis —Burkina Faso, 2014–2015
• Burkina Faso introduced 13-valent pneumococcal conjugate vaccine (PCV13) in 2013.• By 2015, incidence of PCV13 pneumococcal meningitis decreased by 32%.• Large decreases occurred among children aged
Source: Journal of Infection - Category: Infectious Diseases Authors: Dinanib è Kambiré, Heidi M. Soeters, Rasmata Ouédraogo-Traoré, Isaïe Medah, Lassana Sangaré, Issaka Yaméogo, Guetawendé Sawadogo, Abdoul-Salam Ouédraogo, Soumeya Ouangraoua, Lesley McGee, Velusamy Srinivasan, Flavien Aké, Malika Congo-Ouédraogo Source Type: research
More News: Burkina Faso Health | Children | Congo Health | Infectious Diseases | Men | Meningitis | Meningitis Vaccine | Pneomococcal Vaccine | Vaccines